Medicine
Anastrozole
Each fact is a quote from a trusted source. Published 2026-11-17.
These pages do not diagnose conditions.
These pages do not give doses or medicine-taking instructions.
Facts
what it is: Anastrozole is an aromatase inhibitor medication.
Anastrazole is an aromatase inhibitor for use in the treatment of hormone receptor-positive breast cancer.
WHO Electronic Essential Medicines List (eEML)medicine group: Anastrozole is classified as a hormone and antihormone medication.
Hormones and antihormones
WHO Electronic Essential Medicines List (eEML)what it is used for: Anastrozole is used for the treatment of hormone receptor-positive breast cancer.
Anastrazole is an aromatase inhibitor for use in the treatment of hormone receptor-positive breast cancer.
WHO Electronic Essential Medicines List (eEML)essential medicine status: Anastrozole is included on the Essential Medicines List.
Anastrozole Essential medicine status
WHO Electronic Essential Medicines List (eEML)what it is: Anastrozole is a nitrile and triazole derivative.
A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor.
Medical Subject Headings (NLM, NIH)how it works: Anastrozole functions as a selective nonsteroidal aromatase inhibitor.
A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor.
Medical Subject Headings (NLM, NIH)what it is used for: Anastrozole is used to treat estrogen nuclear receptor-positive breast cancer in postmenopausal women.
It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women.
Medical Subject Headings (NLM, NIH)medicine group: Anastrozole is classified as an antineoplastic agent.
Pharm Action Antineoplastic Agents, Hormonal Aromatase Inhibitors
Medical Subject Headings (NLM, NIH)
Sources
- eEML - Electronic Essential Medicines List
WHO Electronic Essential Medicines List (eEML) · retrieved 2026-11-15
- MeSH Browser
Medical Subject Headings (NLM, NIH) · retrieved 2026-11-15